Home/Filings/4/0002065881-25-000011
4//SEC Filing

Matsuda Masaru 4

Accession 0002065881-25-000011

CIK 0001787306other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 8:25 PM ET

Size

5.6 KB

Accession

0002065881-25-000011

Insider Transaction Report

Form 4
Period: 2025-05-28
Matsuda Masaru
See Remarks
Transactions
  • Sale

    Common Stock

    2025-05-28$13.78/sh1,800$24,807202,599 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"), granted on January 3, 2022.
  • [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.64 to $14.16, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Issuer

Arcutis Biotherapeutics, Inc.

CIK 0001787306

Entity typeother

Related Parties

1
  • filerCIK 0001798679

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 8:25 PM ET
Size
5.6 KB